VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...
Welcome to our first fireside chat of the morning. I'm Robert Burns, the Managing Director and Senior Biotech Analyst at H.C. Wainwright. And I'm joined today by Chris Senner, the CFO of Exelixis; as ...
Galderma today announced new data from a first-of-its-kind real-world clinical study conducted in China assessing the biological impact of different lifestyles and their associated environmental ...
Tektronix’s 7 Series DPO oscilloscope claims the industry’s lowest noise and highest ENOB with up to 10× faster data offload.
The New Republic on MSNOpinion
MAGA Rep Is Already Weaponizing Charlie Kirk’s Death for Censorship
President Donald Trump on Wednesday ordered American flags to be flown at half-staff after the deadly shooting of ...
Twitch streamer Hasan Piker could pivot from influencer to candidate. But he tells WIRED’s “Big Interview” podcast he’d ...
Crinetics’ PALSONIFY wins FDA approval as a new oral treatment for acromegaly, offering rapid, effective symptom control.
President suggests Starmer calls in military to stop small boats before heading back to US - The US president says Putin ‘let ...
Progress in RNA-based medicines, immunotherapies and targeted treatments is not simply desirable, it is a critical necessity.
NetworkNewsWire Editorial Coverage NEW YORK, Sept. 17, 2025 /PRNewswire/ -- Progress in RNA-based medicines, immunotherapies and targeted treatments is not simply desirable, it is a critical ...
Congress can’t get it done. But in Washington state, they’ve created a model for the other Washington to build on some day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback